首页> 外国专利> method of eliciting a t-cell response against a t-cell epitope in a mammalian host individual, assay for testing the effectiveness of a method of eliciting a t-cell response, and kit for performing them

method of eliciting a t-cell response against a t-cell epitope in a mammalian host individual, assay for testing the effectiveness of a method of eliciting a t-cell response, and kit for performing them

机译:在哺乳动物宿主个体中引起针对t细胞表位的t细胞应答的方法,用于测试引发t细胞应答的方法的有效性的测定法以及用于进行它们的试剂盒

摘要

"METHOD OF ELICATING A T-CELL RESPONSE AGAINST A T-CELL EPYPE IN A MAMMALIAN HOST GUEST TEST TO TEST THE EFFECTIVENESS OF A T-CELL RESPONSE," KITES TO REAL. The invention relates to a method of eliciting a T cell response against a T cell epitope in a host mammalian subject, which method comprises: (i) a first immunization comprising at least two administrations, which are from 1 to 14 separate days in the individual, wherein each administration comprises administering a nucleotide of interest (NOI) encoding the T cell epitope and optionally (ii) a second immunization comprising at least one administration to the individual of (a) a NOI encoding the T cell epitope or (b) a protein comprising the T cell epitope, wherein the time between the first administration of the first immunization and the first administration of the second immunization is 21 to 365 days.
机译:“在哺乳动物宿主来宾测试中消除针对T细胞表型的T细胞反应的方法,以测试T细胞反应的效果,”实际上如此。本发明涉及在宿主哺乳动物受试者中引起针对T细胞表位的T细胞应答的方法,该方法包括:(i)第一次免疫,其包括至少两次施用,所述两次施用在个体中为1至14天,其中每次给药均包括给予编码T细胞表位的目标核苷酸(NOI)和可选的(ii)第二次免疫,包括对个体进行至少一次给药(a)编码T细胞表位的NOI或(b)包含T细胞表位的蛋白,其中在第一次给予第一次免疫与第一次给予第二次免疫之间的时间为21至365天。

著录项

  • 公开/公告号BRPI0415202A

    专利类型

  • 公开/公告日2006-12-05

    原文格式PDF

  • 申请/专利权人 POWDERJECT VACCINES INC.;

    申请/专利号BR2004PI15202

  • 发明设计人 RALPH PATRICK BRAUN;LICHUN DONG;

    申请日2004-10-12

  • 分类号A61K31/70;A61K39/00;

  • 国家 BR

  • 入库时间 2022-08-21 20:59:28

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号